Krista L. Lanctôt, PhD
Meta-Analysis
Cannabinoids for Agitation and Aggression in AD
January 29, 2019
Given the limited efficacy and questionable safety profiles of current pharmacologic treatments of agitation in Alzheimer's disease (AD), the therapeutic potential of natural and synthetic cannabinoids are being explored...